134 related articles for article (PubMed ID: 19184652)
1. Molecular genetics of nicotine metabolism.
Mwenifumbo JC; Tyndale RF
Handb Exp Pharmacol; 2009; (192):235-59. PubMed ID: 19184652
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition kinetics of nicotine.
Hukkanen J; Jacob P; Benowitz NL
Pharmacol Rev; 2005 Mar; 57(1):79-115. PubMed ID: 15734728
[TBL] [Abstract][Full Text] [Related]
3. CYP2A6: genetics, structure, regulation, and function.
Raunio H; Rahnasto-Rilla M
Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
[TBL] [Abstract][Full Text] [Related]
4. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
Malaiyandi V; Sellers EM; Tyndale RF
Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
[TBL] [Abstract][Full Text] [Related]
5. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
Tricker AR
Toxicology; 2003 Feb; 183(1-3):151-73. PubMed ID: 12504349
[TBL] [Abstract][Full Text] [Related]
6. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
Oscarson M
Drug Metab Dispos; 2001 Feb; 29(2):91-5. PubMed ID: 11159795
[TBL] [Abstract][Full Text] [Related]
8. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
Nakajima M
Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
Tyndale RF; Sellers EM
Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.
von Weymarn LB; Brown KM; Murphy SE
J Pharmacol Exp Ther; 2006 Jan; 316(1):295-303. PubMed ID: 16188955
[TBL] [Abstract][Full Text] [Related]
11. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.
Satarug S; Tassaneeyakul W; Na-Bangchang K; Cashman JR; Moore MR
Curr Clin Pharmacol; 2006 Sep; 1(3):291-309. PubMed ID: 18666753
[TBL] [Abstract][Full Text] [Related]
12. CYP2A6 polymorphism, nicotine, and environmental nitrosamines.
Idle JR
Lancet; 1999 Jun; 353(9169):2073. PubMed ID: 10376647
[No Abstract] [Full Text] [Related]
13. Effects of nicotine on cytochrome P450 2A6 and 2E1 activities.
Hukkanen J; Jacob Iii P; Peng M; Dempsey D; Benowitz NL
Br J Clin Pharmacol; 2010 Feb; 69(2):152-9. PubMed ID: 20233178
[TBL] [Abstract][Full Text] [Related]
14. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.
Nakajima M; Yamagishi S; Yamamoto H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2000 Jan; 67(1):57-69. PubMed ID: 10668854
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
Mwenifumbo JC; Tyndale RF
Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and biochemical effects of nicotine for primary care providers.
Metz CN; Gregersen PK; Malhotra AK
Med Clin North Am; 2004 Nov; 88(6):1399-413, ix. PubMed ID: 15464104
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Sellers EM; Kaplan HL; Tyndale RF
Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
[TBL] [Abstract][Full Text] [Related]
18. Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.
Chenoweth MJ; Zhu AZ; Sanderson Cox L; Ahluwalia JS; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2014 Mar; 24(3):172-6. PubMed ID: 24448396
[TBL] [Abstract][Full Text] [Related]
19. Nicotine metabolism defect reduces smoking.
Pianezza ML; Sellers EM; Tyndale RF
Nature; 1998 Jun; 393(6687):750. PubMed ID: 9655391
[No Abstract] [Full Text] [Related]
20. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
